Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates

Gene Therapy (2013) 20, 465 & 2013 Macmillan Publishers Limited All rights reserved 0969-7128/13 www.nature.com/gt CORRIGENDUM Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates SJ Gray, S Nagabhushan Kalburgi, TJ McCown and R Jude Samulski Gene Therapy (2013) 20, 465; doi:10.1038/gt.2013.11 Correction to: Gene Therapy (2013) 20, 450–459; doi:10.1038/ gt.2012.101; published online 10 January 2013 Since the online publication of this article, the following errors have been identified. In Figure 2b, the black bars indicate AAV9 (101-IC and 102-IC) and the white bars indicate AAV2.5 (103-IC and 104-IC). Figure 2a was labeled correctly. In Figure 5, panels F and G were mislabeled: panel F should be spleen and panel G should be liver. Similarly, in Supplementary Figure 4, panel E should be spleen and panel F should be liver. The corrected article appears in this issue, and the html and PDF versions online have also been amended. The authors would like to apologize for these errors.  (...truncated)